Aadi Accounts Payable vs Other Stockholder Equity Analysis
| AADI Stock | USD 2.31 0.09 4.05% |
Aadi Bioscience financial indicator trend analysis is way more than just evaluating Aadi Bioscience prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aadi Bioscience is a good investment. Please check the relationship between Aadi Bioscience Accounts Payable and its Other Stockholder Equity accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.
Accounts Payable vs Other Stockholder Equity
Accounts Payable vs Other Stockholder Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aadi Bioscience Accounts Payable account and Other Stockholder Equity. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Aadi Bioscience's Accounts Payable and Other Stockholder Equity is 0.86. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of Aadi Bioscience, assuming nothing else is changed. The correlation between historical values of Aadi Bioscience's Accounts Payable and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Aadi Bioscience are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Accounts Payable i.e., Aadi Bioscience's Accounts Payable and Other Stockholder Equity go up and down completely randomly.
Correlation Coefficient | 0.86 |
| Relationship Direction | Positive |
| Relationship Strength | Strong |
Accounts Payable
An accounting item on the balance sheet that represents Aadi Bioscience obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Aadi Bioscience are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Other Stockholder Equity
Most indicators from Aadi Bioscience's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aadi Bioscience current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.As of now, Aadi Bioscience's Enterprise Value Multiple is increasing as compared to previous years.
| 2021 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 105K | 159K | 171K | 122.1K | Interest Income | 13K | 2.4M | 6.5M | 6.8M |
Aadi Bioscience fundamental ratios Correlations
Click cells to compare fundamentals
Aadi Bioscience Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Aadi Bioscience fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 39.9M | 18.8M | 157.9M | 184.2M | 132.4M | 139.0M | |
| Total Stockholder Equity | 36.5M | (12.4M) | 136.4M | 158.4M | 105.2M | 110.5M | |
| Net Debt | (38.4M) | 5.8M | (148.4M) | (37.4M) | (61.6M) | (58.5M) | |
| Retained Earnings | (142.2M) | (32.6M) | (142.7M) | (203.2M) | (269.0M) | (255.5M) | |
| Cash | 38.5M | 4.5M | 149.0M | 39.0M | 62.9M | 66.0M | |
| Cash And Short Term Investments | 38.5M | 4.5M | 149.0M | 172.6M | 108.8M | 114.3M | |
| Common Stock Shares Outstanding | 2.7M | 2.5M | 8.9M | 22.5M | 26.9M | 28.3M | |
| Liabilities And Stockholders Equity | 39.9M | 18.8M | 157.9M | 184.2M | 132.4M | 139.0M | |
| Other Stockholder Equity | 179.1M | 20.2M | 279.1M | 361.7M | 374.1M | 392.8M | |
| Total Current Assets | 39.6M | 18.7M | 151.3M | 180.0M | 124.6M | 130.8M | |
| Total Current Liabilities | 3.3M | 30.1M | 15.3M | 18.8M | 26.4M | 27.7M | |
| Total Liab | 3.4M | 31.3M | 21.5M | 25.9M | 27.2M | 28.6M | |
| Other Current Liab | 2.8M | 99K | 8.7M | 14.5M | 20.1M | 21.1M | |
| Accounts Payable | 439.8K | 2.4M | 6.4M | 3.5M | 5.9M | 6.2M | |
| Other Current Assets | 1.0M | 81K | 4.6M | 3.7M | 3.8M | 4.0M | |
| Non Current Assets Total | 366.3K | 140K | 6.6M | 4.2M | 7.8M | 8.2M | |
| Non Currrent Assets Other | 40.0K | (140K) | 2.2M | 2.1M | 1.9M | 2.0M | |
| Property Plant And Equipment Net | 326.3K | 140K | 614K | 2.0M | 6.0M | 6.3M | |
| Accumulated Other Comprehensive Income | (335.8K) | (311.1K) | (328.9K) | (115K) | 27K | 28.4K | |
| Property Plant And Equipment Gross | 326.3K | 185.6K | 614K | 2.0M | 6.2M | 6.6M | |
| Net Tangible Assets | (9.1M) | 43.1M | 132.6M | 158.4M | 182.1M | 191.2M | |
| Property Plant Equipment | 316.0K | 121.7K | 57K | 2.0M | 2.3M | 2.5M |
Currently Active Assets on Macroaxis
When determining whether Aadi Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aadi Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aadi Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aadi Bioscience Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.28) | Revenue Per Share 0.929 | Quarterly Revenue Growth 0.21 | Return On Assets (0.35) | Return On Equity (0.66) |
The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.